Table of Contents
Journal of Radiotherapy
Volume 2014, Article ID 703764, 7 pages
http://dx.doi.org/10.1155/2014/703764
Clinical Study

Intensity-Modulated Radiotherapy with a Simultaneous Integrated Boost Combined with Chemotherapy in Stages III-IV Hypopharynx-Larynx Cancer: Treatment Compliance and Clinical Outcomes

1Division of Radiotherapy, Centro di Riferimento Oncologico, IRCCS, Via F. Gallini 2, 33081 Aviano, Italy
2Division of Medical Oncology, Centro di Riferimento Oncologico, IRCCS, Via F. Gallini 2, 33081 Aviano, Italy
3Unit of Epidemiology and Biostatistics, Centro di Riferimento Oncologico, IRCCS, Via F. Gallini 2, 33081 Aviano, Italy
4Division of Head and Neck, General Hospital “Santa maria degli Angeli”, Via Montereale 24, 33170 Pordenone, Italy
5Department of Medical Physics, Centro di Riferimento Oncologico, IRCCS, Via F. Gallini 2, 33081 Aviano, Italy

Received 18 September 2013; Revised 6 December 2013; Accepted 20 December 2013; Published 30 January 2014

Academic Editor: Georgios Plataniotis

Copyright © 2014 Giovanni Franchin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J.-P. Pignon, A. le Maître, E. Maillard, and J. Bourhis, “Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients,” Radiotherapy & Oncology, vol. 92, no. 1, pp. 4–14, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Johnson-Obaseki, J. T. McDonald, M. Corsten, and R. Rourke, “Head and neck cancer in Canada: trends 1992 to 2007,” Otolaryngoly, vol. 147, no. 1, pp. 74–78, 2012. View at Publisher · View at Google Scholar
  3. National Comprehensive Cancer Network: H&N Cancers Version 1, 2010, http://www.nccn.org/ professionals/physician_gls/PDF/head-and-neck.
  4. J. P. Pignon, J. Bourhis, C. Domenge, and L. Designé, “Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data,” The Lancet, vol. 355, no. 9208, pp. 949–955, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. J. P. Pignon, A. le Maître, and J. Bourhis, “Meta-analysis of chemo-therapy in head and neck cancer (MACH-NC): an update,” International Journal of Radiation Oncology, Biology, Physics, vol. 69, no. 2, pp. S112–S114, 2007. View at Publisher · View at Google Scholar
  6. C. Nutting, R. A’Hern, M. S. Rogers et al., “First results of a phase III multicenter randomized controlled trial of intensity modulated (IMRT) versus conventional radiotherapy (RT) in head and neck cancer,” The Lancet Oncology, vol. 12, no. 2, pp. 127–136, 2011. View at Publisher · View at Google Scholar
  7. W. Budach, T. Hehr, V. Budach, C. Belka, and K. Dietz, “A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck,” BMC Cancer, vol. 6, article 28, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Bourhis, J. Overgaard, H. Audry et al., “Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis,” The Lancet, vol. 368, no. 9538, pp. 843–854, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. D. J. Adelstein, Y. Li, G. L. Adams et al., “An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer,” Journal of Clinical Oncology, vol. 21, no. 1, pp. 92–98, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Calais, M. Alfonsi, E. Bardet et al., “Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma,” Journal of the National Cancer Institute, vol. 91, no. 24, pp. 2081–2086, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. A. A. Forastiere, H. Goepfert, M. Maor et al., “Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer,” The New England Journal of Medicine, vol. 349, pp. 2091–2098, 2003. View at Publisher · View at Google Scholar
  12. R. Haddad, A. O'Neill, G. Rabinowits et al., “NCT followed by CRT (sequential chemoradiotherapy) versus CRT alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial,” The Lancet Oncology, vol. 14, no. 3, pp. 257–264, 2013. View at Google Scholar
  13. J. H. Lorch, O. Goloubeva, R. I. Haddad et al., “Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial,” The Lancet Oncology, vol. 12, no. 2, pp. 153–159, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. J. B. Vermorken, E. Remenar, C. van Herpen et al., “Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer,” The New England Journal of Medicine, vol. 357, no. 17, pp. 1695–1704, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. M. R. Posner, D. M. Hershock, C. R. Blajman et al., “Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer,” The New England Journal of Medicine, vol. 357, no. 17, pp. 1705–1715, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Pointreau, P. Garaud, S. Chapet et al., “Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation,” Journal of the National Cancer Institute, vol. 101, no. 7, pp. 498–506, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. M. W. Münter, C. P. Karger, S. G. Hoffner et al., “Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy,” International Journal of Radiation Oncology, Biology, Physics, vol. 58, no. 1, pp. 175–184, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. K. S. Chao, N. Majhail, C.-J. Huang et al., “Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques,” Radiotherapy & Oncology, vol. 61, no. 3, pp. 275–280, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. E. H. N. Pow, D. L. W. Kwong, A. S. McMillan et al., “Xerostomia and quality of life after intensity-modulated radiotherapy vs. Conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial,” International Journal of Radiation Oncology, Biology, Physics, vol. 66, no. 4, pp. 981–991, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. S. B. Edge, D. R. Byrd, C. C. Compton, A. G. Fritz, F. L. Greene, and A. Trotti, Eds., The American Joint Committee Cancer Staging Manual, Springer, New York, NY, USA, 7th edition, 2010.
  21. E. L. Kaplan and P. Meier, “Non-parametric estimation from incomplete observations,” Journal of the American Statistical Association, vol. 53, no. 282, pp. 457–481, 1958. View at Google Scholar
  22. P. Blanchard, B. Baujat, V. Holostenco et al., “Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site,” Radiotherapy & Oncology, vol. 100, no. 1, pp. 33–40, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Sanguinetti, “Oncology scan—rethinking treatment strategies for cancers of the larynx and pharynx,” International Journal of Radiation Oncology, Biology, Physics, vol. 86, no. 5, pp. 805–807, 2013. View at Publisher · View at Google Scholar
  24. Tumori in Italia, “La sopravvivenza dei pazienti oncologici in Italia,” Rapporto AIRTUM, 2011. View at Google Scholar
  25. R. Olson, F. Wong, J. Wu, W. Cheung, and J. Hay, “25 year survival outcomes for SCC of the H&N: population based outcomes for BC,” in Proceedings of the 54th ASTRO Meeting, BC Cancer Agency, Boston, Mass, USA, 2012.
  26. R. Kazi, R. Venkitaraman, C. Johnson et al., “Electroglottographic comparison of voice outcomes in patients with advanced laryngopharyngeal cancer treated by chemoradiotherapy or total laryngectomy,” International Journal of Radiation Oncology, Biology, Physics, vol. 70, no. 2, pp. 344–352, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Studer, E. Peponi, S. Kloeck, T. Dossenbach, G. Huber, and C. Glanzmann, “Surviving hypopharynx-larynx carcinoma in the era of IMRT,” International Journal of Radiation Oncology, Biology, Physics, vol. 77, no. 5, pp. 1391–1396, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Y. Lee, W. O'Meara, K. Chan et al., “Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers,” International Journal of Radiation Oncology, Biology, Physics, vol. 69, no. 2, pp. 459–468, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. A. B. Miah, S. A. Bhide, M. T. Guerrero-Urbano et al., “Dose-escalated intensity-modulated radiotherapy is feasible and may improve locoregional control and laryngeal preservation in laryngo-hypopharyngeal cancers,” International Journal of Radiation Oncology, Biology, Physics, vol. 82, no. 2, pp. 539–547, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Overgaard, B. K. Mohanti, N. Begum et al., “Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial,” The Lancet Oncology, vol. 11, no. 6, pp. 553–560, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Franchin, E. Vaccher, R. Talamini et al., “Intensity-modulated radiotherapy (IMRT)/tomotherapy following neoadjuvant chemotherapy in stage IIB-IVA/B undifferentiated nasopharyngeal carcinomas (UCNT): a mono-institutional experience,” Oral Oncology, vol. 47, no. 9, pp. 905–909, 2011. View at Publisher · View at Google Scholar · View at Scopus